These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10519945)

  • 1. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
    Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
    Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.
    Straubinger RK; Chang YF; Jacobson RH; Appel MJ
    J Clin Microbiol; 1995 Oct; 33(10):2745-51. PubMed ID: 8567917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.
    Chang YF; McDonough SP; Chang CF; Shin KS; Yen W; Divers T
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):68-71. PubMed ID: 10618280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
    Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
    Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
    Johnson BJ; Sviat SL; Happ CM; Dunn JJ; Frantz JC; Mayer LW; Piesman J
    Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
    Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
    J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J
    Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
    Kurtti TJ; Munderloh UG; Hughes CA; Engstrom SM; Johnson RC
    Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection of ponies with Borrelia burgdorferi by exposure to Ixodid ticks.
    Chang YF; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
    Vet Pathol; 2000 Jan; 37(1):68-76. PubMed ID: 10643983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
    Golde WT; Piesman J; Dolan MC; Kramer M; Hauser P; Lobet Y; Capiau C; Desmons P; Voet P; Dearwester D; Frantz JC
    Infect Immun; 1997 Mar; 65(3):882-9. PubMed ID: 9038292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
    Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
    Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.
    Gern L; Hu CM; Voet P; Hauser P; Lobet Y
    Vaccine; 1997 Oct; 15(14):1551-7. PubMed ID: 9330467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.
    Croke CL; Munson EL; Lovrich SD; Christopherson JA; Remington MC; England DM; Callister SM; Schell RF
    Infect Immun; 2000 Feb; 68(2):658-63. PubMed ID: 10639430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
    Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
    Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.